Table 7.
Combined effects of nano-TiO2 on various organs
| Exposed route | Livera | Spleena | Kidneya | Lunga | Braina | Hearta | Totala | Percentageb |
|---|---|---|---|---|---|---|---|---|
| Digestive tract |
3/0 |
0/1 |
3/0 |
0/1 |
1/0 |
0/1 |
7/3 |
70 |
| Respiratory tract |
4/0 |
1/1 |
2/1 |
12/3 |
1/1 |
0/2 |
20/8 |
71 |
| Intraperitoneal injection |
7/2 |
1/1 |
5/1 |
2/2 |
1/0 |
2/1 |
18/7 |
72 |
| Skin |
1/0 |
1/0 |
1/0 |
1/0 |
0/1 |
0/1 |
4/2 |
67 |
| Caudal vein |
1/0 |
0/0 |
2/0 |
0/0 |
0/0 |
0/0 |
3/0 |
100 |
| Totala |
16/2 |
3/3 |
13/2 |
15/6 |
3/2 |
2/5 |
52/20 |
- |
| Percentageb | 89 | 50 | 87 | 71 | 60 | 29 | 72 | - |
aNumber of positive/negative studies.
bPercentage of positive studies.